Related Experiment Video
Updated: Jul 19, 2026

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
Published on: October 28, 2014
Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis
Andrew M Schumacher1, Anastasia V Velentza, D Martin Watterson
1Center for Drug Discovery and Chemical Biology, Northwestern University, 303 East Chicago Avenue, W-896, Chicago, Illinois 60611, USA.
Abstract:
Death-associated protein kinase (DAPK) is a pro-apoptotic, calcium/calmodulin-regulated protein kinase that is a drug discovery target for neurodegenerative disorders. Despite the potential profound physiological role of DAPK in neuronal function and pathophysiology, the endogenous substrate(s) of this kinase and the mechanisms via which DAPK elicits its biological action remain largely unknown. We report here that the mammalian 40S ribosomal protein S6 is a DAPK substrate. Results from immunoprecipitation experiments are consistent with endogenous DAPK being associated with endogenous S6 in rat brain. When S6 is a component of the 40S ribosomal subunit complex, DAPK selectively phosphorylates it at serine 235, one of the five sites in S6 that are phosphorylated by the S6 kinase family of proteins. The amino acid sequence flanking serine 235 matches the established pattern for DAPK peptide and protein substrates. Kinetic analyses using purified 40S subunits revealed a K(m) value of 9 microM, consistent with S6 being a potential physiological substrate of DAPK. This enzyme-substrate relationship has functional significance. DAPK suppresses translation in rabbit reticulocyte lysate, and treatment of neuroblastoma cells with a stimulator of DAPK reduces protein synthesis. In both cases, suppression of translation correlates with increased phosphorylation of S6 at serine 235. These results demonstrate that DAPK is a S6 kinase and provide evidence for a novel role of DAPK in the regulation of translation.
Insights
Death-associated protein kinase (DAPK) phosphorylates ribosomal protein S6, revealing a novel mechanism for regulating protein synthesis and offering new therapeutic targets for neurodegenerative disorders.
Area of Science:
- Molecular Biology
- Neuroscience
- Biochemistry
Background:
- Death-associated protein kinase (DAPK) is a key regulator of apoptosis and a potential therapeutic target for neurodegenerative diseases.
- The precise physiological substrates and functions of DAPK in neuronal cells are not fully understood.
Purpose of the Study:
- To identify endogenous substrates of DAPK.
- To investigate the role of DAPK in protein synthesis regulation.
Main Methods:
- Immunoprecipitation assays to detect DAPK-S6 association in rat brain.
- In vitro kinase assays using purified 40S ribosomal subunits.
- Translation assays in rabbit reticulocyte lysate and neuroblastoma cells.
Main Results:
- Mammalian 40S ribosomal protein S6 was identified as a direct substrate of DAPK.
- DAPK selectively phosphorylates S6 at serine 235.
- DAPK-mediated S6 phosphorylation correlates with the suppression of protein synthesis.
Conclusions:
- DAPK acts as an S6 kinase, directly phosphorylating S6 at serine 235.
- DAPK plays a novel role in regulating translation, potentially through S6 phosphorylation.
- This discovery provides new insights into DAPK's function in neuronal pathophysiology and disease treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibitors of Bacterial Protein Synthesis
The JAK-STAT Signaling Pathway
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Translational Regulation

